|
Letermovir 480 MG [Prevymis] Clinical Trials
1 actively recruiting trial across 1 location
Philadelphia, Pennsylvania1 trial
Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
Penn Medicine at the University of Pennsylvania
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.